Adequacy of Olmesartan Monotherapy Versus Cotherapy in Patients With Essential Hypertension

International Journal of Research in Pharmaceutical Sciences- India

doi 10.26452/ijrps.v11i2.2047

Full Text

Abstract

Available in

Date

Authors

Publisher

GP Innovations Pvt. Ltd.

Related search

Erratum To: Efficacy and Safety of Olmesartan Medoxomil 40 Mg/Hydrochlorothiazide 12.5 Mg Combination Therapy Versus Olmesartan Medoxomil 40 Mg Monotherapy in Patients With Moderate to Severe Hypertension

Clinical Drug Investigation
MedicinePharmacology
2012English

The Effect of Olmesartan Monotherapy on Serum Lipid Profiles in Patients With Hypertension: An Observational Longitudinal Study

Journal of Nihon University Medical Association
2016English

Ketanserin, a Novel 5-Hydroxytryptamine Antagonist: Monotherapy in Essential Hypertension.

British Journal of Clinical Pharmacology
Pharmacology
1983English

Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

BMC Psychiatry
PsychiatryMental Health
2014English

Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease

International Journal of Nephrology and Renovascular Disease
Nephrology
2013English

Treatment Persistence With Combination Versus Monotherapy in Commercially Insured Patients With Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Antiplatelet Adequacy of Cyclopentyl Triazolopyrimidine Versus Clopidogrel In-Patients With Coronary Heart Disease

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Elevated Blood Viscosity in Patients With Borderline Essential Hypertension

Hypertension
Internal Medicine
1983English

Propranolol Increases Prostacyclin Synthesis in Patients With Essential Hypertension

Hypertension
Internal Medicine
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy